13F HOLDINGS REPORT
GENERAL ATLANTIC, L.P.
Quarter ended Q4 2024 · Filed February 7, 2025 · Accession 0000950142-25-000283
Total Value
$2.81B
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DLOCAL | DLO | 63,906,695 | $719.6M | 25.61% |
| 2 | ALIGNMENT HEALTHCARE | ALHC | 60,993,323 | $686.2M | 24.43% |
| 3 | ALKAMI | ALKT | 9,645,318 | $353.8M | 12.59% |
| 4 | XP, INC | XP | 29,617,733 | $351.0M | 12.49% |
| 5 | CENTESSA PHARMACEUTICALS | CNTA | 9,681,818 | $162.2M | 5.77% |
| 6 | AKERO THERAPEUTICS | 00973Y108 | 5,233,989 | $145.6M | 5.18% |
| 7 | PHARVARIS | PHVS | 7,531,252 | $144.4M | 5.14% |
| 8 | EUROPEAN WAX CENTER | 29882P106 | 13,110,492 | $87.4M | 3.11% |
| 9 | ROYALTY PHARMA | RPRX | 1,500,000 | $38.3M | 1.36% |
| 10 | IMMUNOCORE | IMCR | 1,261,684 | $37.2M | 1.32% |
| 11 | THIRD HARMONIC BIO | 88427A107 | 3,372,323 | $34.7M | 1.24% |
| 12 | RISKIFIED | RSKD | 5,324,998 | $25.2M | 0.90% |
| 13 | ACELYRIN | 00445A100 | 2,695,327 | $8.5M | 0.30% |
| 14 | ADAGENE | ADAG | 3,825,952 | $7.6M | 0.27% |
| 15 | WISH | LOGC | 609,616 | $4.3M | 0.15% |
| 16 | GROVE COLLABORATIVE | GROVW | 2,474,859 | $3.4M | 0.12% |